No abstract available
Publication types
- News
- Research Support, Non-U.S. Gov't
MeSH terms
- Adenosine Monophosphate / analogs & derivatives
- Adenosine Monophosphate / therapeutic use
- Alanine / analogs & derivatives
- Alanine / therapeutic use
- Antiviral Agents / therapeutic use*
- Betacoronavirus* / drug effects
- Betacoronavirus* / genetics
- Betacoronavirus* / pathogenicity
- COVID-19
- COVID-19 Drug Treatment
- Coronavirus Infections / drug therapy*
- Drug Repositioning*
- HIV Infections / drug therapy
- Hepatitis B / drug therapy
- Hepatitis C / drug therapy
- Humans
- Influenza, Human / drug therapy
- Interferon-alpha / pharmacology
- Interferon-alpha / therapeutic use
- Middle East Respiratory Syndrome Coronavirus / drug effects
- Middle East Respiratory Syndrome Coronavirus / genetics
- Middle East Respiratory Syndrome Coronavirus / pathogenicity
- Nucleosides* / pharmacology
- Nucleosides* / therapeutic use
- Pneumonia, Viral / drug therapy*
- Polyethylene Glycols / pharmacology
- Polyethylene Glycols / therapeutic use
- Protease Inhibitors* / pharmacology
- Protease Inhibitors* / therapeutic use
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- SARS-CoV-2
- Severe acute respiratory syndrome-related coronavirus / drug effects
- Severe acute respiratory syndrome-related coronavirus / genetics
- Severe acute respiratory syndrome-related coronavirus / pathogenicity
- Spike Glycoprotein, Coronavirus / drug effects
Substances
- Antiviral Agents
- Interferon-alpha
- Nucleosides
- Protease Inhibitors
- Recombinant Proteins
- Spike Glycoprotein, Coronavirus
- remdesivir
- Polyethylene Glycols
- Adenosine Monophosphate
- Alanine
- peginterferon alfa-2a